Reduced dose of warfarin alternative may help prevent strokes in dialysis patients
In dialysis patients who took 2.5 mg of apixaban twice daily, blood concentrations of the drug were maintained at therapeutic levels. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 16, 2017 Category: Science Source Type: news
Estimating the Benefit of Warfarin in Individuals With AF Estimating the Benefit of Warfarin in Individuals With AF
This study focuses on the need to balance the benefits of long-term anticoagulant therapy for AF with an individual ' s life expectancy and risk of dying from nonthromboembolic causes.Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 10, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Dose-Adjusted DOACs: What Efficacy vs Warfarin?
Patients who require dose adjustment when taking direct oral anticoagulants have not been well studied. This large study is a good start. (Source: ConsultantLive)
Source: ConsultantLive - March 6, 2017 Category: Internal Medicine Authors: Payal Kohli, MD Tags: Atrial Fibrillation Cardiovascular Diseases Cerebrovascular Diseases Source Type: news
Genotype-guided warfarin cost effective in Asian MHVR patients
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - February 28, 2017 Category: Drugs & Pharmacology Source Type: news
NOACs Are Favored Over Warfarin: I'm (Almost) Okay With That NOACs Are Favored Over Warfarin: I'm (Almost) Okay With That
Clinical experience with the new direct-acting oral anticoagulants (DOACs or NOACs) is reassuring, says Dr Mandrola, but independent confirmatory analysis of the data would be even better.theheart.org on Medscape (Source: theHeart.org)
Source: theHeart.org - February 27, 2017 Category: Cardiology Tags: Cardiology Expert Column Source Type: news
